Clinical Trials Directory

Trials / Completed

CompletedNCT04264130

Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection

Evaluation of the Effect of Artemisinin-based Combination Therapies on Urinary Schistosoma Haematobium When Administered for the Treatment of Malaria Co-infection

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Centre de Recherche Médicale de Lambaréné · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Open labelled, non randomized study to evaluate the effects of Artemisinin based Combined Therapies(ACTs) on schistosomiasis since Praziquantel (PZQ) which is presently the drug of choice for treating Schistosomiasis (STS), is ineffective on immature stages and there is known parasite resistance. ACTs when combined with PZQ, targeting different stages of the life cycle has shown some effectivity.

Detailed description

Study population included all subjects in study area who signed a written Informed Consent Form diagnosed with Malaria- STS co-infection. Those excluded were treated with PZQ prior 6 weeks, have drug intolerance or pregnant. At Inclusion, Basic Demographic data was recorded and urine samples analysed. During the follow up visits, urine samples were collected on D28 and D42 (6 weeks post treatment). Post treatment assessment was done on urine samples collected on at least two consecutive days and at the end of follow up, all subjects were treated with a single dose pf PZQ (40 mg/kg) as recommended by WHO.

Conditions

Interventions

TypeNameDescription
DRUGArtesunate-PyronaridineSubjects received artesunate-pyronaridine according to their body weight once per day for three days.
DRUGArtemether-Lumefantrinesubjects received artemether-lumefantrine according to their body weight twice per day for three days.
DRUGArtefenomel-FerroquineSubject received a single dose of artefenomel-ferroquine according to their body weight

Timeline

Start date
2018-07-31
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2020-02-11
Last updated
2020-02-11

Locations

1 site across 1 country: Gabon

Source: ClinicalTrials.gov record NCT04264130. Inclusion in this directory is not an endorsement.